NEW YORK—The Fordham University Center for Ethics Education will bring together influential stakeholders in the biopharmaceutical industry for a two-day summit titled “Biopharmaceuticals for the 21st Century: Responsibility, Sustainability and Public Trust” on Monday, Jan. 10, and Tuesday, Jan. 11, 2005 at the Lincoln Center campus.

The summit will open with a keynote address by U.S. Rep. Diana DeGette (D-Colo.), a member of the House Energy and Commerce Committee, on Monday, Jan. 10, at 3 p.m., in the McNally Amphitheatre, Fordham University School of Law, 140 W. 62nd St. DeGette’s congressional committee has jurisdiction over healthcare, trade, business, technology and consumer protection. Her address will be followed by a panel discussion on biopharmaceuticals and public trust.

The summit is the first of a series that will provide a forum for pharmaceutical executives, government regulators, public advocates and members of the medical community to openly discuss the challenges of balancing social responsibility and profitability. The summit will result in a list of recommendations that will guide legislative policy. For a schedule of summit sessions and speakers, visit

TIME:    3-5:30 P.M.
140 W. 62ND, NEW YORK, NY

The Jan. 10 panelists will include:
Representing the public and the pharmaceutical industry:
Jill Guary, C.C.R.C., director for clinical research at Harris Interactive
Marc Boutin, vice president for policy development and advocacy at the National Health Council
Laurence Hirsch, executive director of Medical Communications at Merck Research Laboratories

Representing the regulatory and legal perspectives:
Bernard Schwetz, D.V.M., Ph.D., director of the Office for Human Research Protections
Theresa Toigo, R.Ph., director of the Office of Special Health Issues Office of External Relations at the Food and Drug Administration
Bill Leedom, an attorney at Bennett, Bigelow and Leedom
Alan Milstein, an attorney at Sherman, Silverstein, Kohl, Rose & Podolsky

On Jan. 11, 50 national figures from the healthcare and pharmaceutical industries, regulatory agencies, patient advocacy groups, clinical research organizations, institutional review boards, and medical and psychiatric professional associations will meet to develop recommendations for legislation involving “Clinical Trials Registries: Responsible Practice and Public Access.” The Jan. 11 forum will be open to the select media by special invitation only.

The Fordham University Center for Ethics Education was created in 1999 to contribute to Fordham’s commitment to cultivating lifelong habits of critical thinking, moral reflection and articulate expression. The Center sponsors activities that provide students, faculty, professionals and the public with knowledge and skills to study, inform and shape a just society that nurtures the full-flourishing of peoples of diverse faiths and cultures.